
Quarterly Result4 Nov 2026, 01:37 pm
Marksans Pharma Declares Unaudited Q2 FY27 Financial Results
AI Summary
Marksans Pharma Ltd announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results at a meeting held on November 04, 2026. The company's statutory auditors, MSKA & Associates LLP, have submitted their Limited Review Reports with an unmodified opinion.
Key Highlights
- Unaudited financial results for Q2 FY27 declared.
- Both standalone and consolidated results were approved.
- Board meeting held on November 04, 2026.
- Auditors issued an unmodified opinion.
- Results available on the company website.
Price Impact
More from MARKSANS